Addressing the Fear of Cancer Recurrence in Family Caregivers
Study Overview
This study focuses on the fear of cancer recurrence (FCR) experienced by family caregivers (FC) of cancer patients. FCR can lead to a lower quality of life and increased psychological distress. The goal was to test the Family Caregiver-Fear Of Recurrence Therapy (FC-FORT) to see if it is practical and effective.
Methodology
The study involved a two-group randomized control trial, comparing the FC-FORT group with a waitlist control group. Women caregivers were recruited through hospitals and social media. The intervention group participated in 7 weekly virtual therapy sessions and completed surveys at different stages to assess the therapy’s feasibility and acceptability.
Key Findings
- Feasibility: 22 caregivers were recruited; 18 completed the study with high therapist fidelity (87%).
- Acceptability: 67% attended at least 5 sessions, with an 80% satisfaction rate among participants.
- Questionnaire Completion: 92% of participants completed the required forms.
- Group Feedback: Caregivers reported the therapy as helpful and expressed the need for improvements.
Conclusions
This study is one of the first to address FCR in family caregivers. While the therapy was generally well-received, further improvements are necessary before conducting a larger trial.
Clinical Trials and Beyond
Clinical trials are essential for developing effective treatments. To enhance these efforts, DocSym offers an AI-driven platform that consolidates clinical guidelines and research for easy access by healthcare professionals. Our mobile apps facilitate efficient patient management, including scheduling and telemedicine, streamlining operations to improve care.
By integrating AI, healthcare clinics can optimize their workflows, enhance patient outcomes, and reduce reliance on paper processes. Discover more about our solutions at aidevmd.com.
